Relationship Between Serum 1,25-dihydroxy Vitamin D and Markers of Bone Metabolism in Renal Dysfunction Patients

Chronic Kidney Disease-Mineral and Bone Disorder Clinical Trial

Official title:
Relationship Between Serum 1,25-dihydroxy Vitamin D and Markers of Bone Metabolism in Renal Dysfunction Patients

Status Completed

Clinical Trial Summary

This cross-sectional study was conducted, including those subjects tested for 1,25(OH)2D during Jan 2015-Dec 2021. Estimated glomerular filtration rate (eGFR) was calculated and subjects were classified into chronic kidney disease (CKD) stages. Associations between biochemical marker, calcium, phosphorus, magnesium, alkaline phosphatase, 1,25(OH)2D and CKD stages was determined.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05399251
Study type	Observational [Patient Registry]
Source	Aga Khan University Hospital, Pakistan
Contact
Status	Completed
Phase
Start date	January 1, 2015
Completion date	December 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04564924` - To Investigate the Bone and Muscle Abnormalities in Patients With Chronic Kidney Disease With MRI
Recruiting	`NCT04714918` - Chinese CKD-MBD Prevalence Survey (CRISS-MBD)
Recruiting	`NCT06288451` - DePTH: De-emphasize PTH	Phase 2
Completed	`NCT04750460` - Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).	Phase 3
Recruiting	`NCT05439980` - Improving Phosphate Control in Children With CKD
Recruiting	`NCT05096195` - PRevEnting FracturEs in REnal Disease 1	Phase 4
Recruiting	`NCT05242055` - Integrated Diagnosis and Treatment of CKD on Outcomes
Recruiting	`NCT04522622` - Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease	Phase 4
Recruiting	`NCT05720273` - Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients	Phase 4